Geodon / Ziprasidone

Modified on 2009/10/14 21:46 by admin
Geodon, also known as ziprasidone, is a drug used to treat schizophrenia. The drug was approved by the Food and Drug Administration (FDA) in February 2001 and is manufactured by Pfizer Pharmaceuticals.

Prior to FDA approval there was significant concern that ziprasidone or Geodon could cause heart rhythm irregularities. While Geodon won approval in spite of these concerns, doctors have been advised to monitor their Geodon patients closely in an effort to spot heart rhythm problems early.

In September 2003, the FDA recommended that six atypical antipsychotics, including Geodon, carry a diabetes warning because of a study that linked three of the six medications to the disorder.

In September 2004, FDA and Pfizer notified healthcare professionals of revision to the WARNINGS section of labeling for Geodon (ziprasidone), describing the risk of hyperglycemia and diabetes in patients taking Geodon. FDA asked all manufacturers of atypical antipsychotic medications, including Pfizer, to add this Warning statement to labeling.

See your doctor if you have experienced serious side effects associated with Geodon. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Antidepressants & Other Psychiatric Drugs
  2. Arrhythmia: Overview
  3. Diabetes
  4. QT Interval: Overview
  5. Tardive Dyskinesia
  Name Size